[Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy].

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.17116/jnevro2017117623-10PMID 28980606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha-synuclein and iron: two keys unlocking Parkinson’s disease

  2017cited by this paper
• Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab‐treated multiple sclerosis

  2017cited by this paper
• CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

  2017cited by this paper
• Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice

  2017cited by this paper
• FTY720 (Fingolimod) reverses &agr;‐synuclein‐induced downregulation of brain‐derived neurotrophic factor mRNA in OLN‐93 oligodendroglial cells

  2017cited by this paper
• Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy

  2017cited by this paper
• Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease

  2017cited by this paper
• Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson’s disease

  2017cited by this paper
• Multiple sclerosis‐associated retrovirus, Epstein‐Barr virus, and vitamin D status in patients with relapsing remitting multiple sclerosis

  2017cited by this paper
• Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)

  2016cited by this paper
• Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

  2016cited by this paper
• Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.

  2016cited by this paper
• Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.

  2016cited by this paper
• Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.

  2016cited by this paper
• Ibudilast for the treatment of multiple sclerosis

  2016cited by this paper
• Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association

  2016cited by this paper
• The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

  2016cited by this paper
• Interferon‐β may ameliorate synucleinopathy

  2016cited by this paper
• Производные амантадина в лечении болезни Паркинсона

  2016cited by this paper
• Современные представлени я об этиоло гии болезни Паркинсона

  2015cited by this paper
• Vitamin D from different sources is inversely associated with Parkinson disease

  2015cited by this paper
• Vagotomy and subsequent risk of Parkinson's disease

  2015cited by this paper
• Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease

  2015cited by this paper
• Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review

  2015cited by this paper
• Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders

  2015cited by this paper
• Modulation of endoplasmic reticulum stress in Parkinson's disease.

  2015cited by this paper
• Infectious Burden and Cognitive Decline in the Northern Manhattan Study

  2015cited by this paper
• Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.

  2014cited by this paper
• Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats

  2014cited by this paper
• [Brain metabolism in multiple sclerosis: effects of neurotrophic therapy].

  2013cited by this paper
• Long-term statin use and the risk of Parkinson's disease.

  2013cited by this paper
• Значение определения белков-маркеров амилоидоза и нейродегенерации в цереброспинальной жидкости в диагностике когнитивных расстройств сосудистого и нейродегенеративного генеза

  2013cited by this paper
• Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis

  2013cited by this paper
• [Brain metabolism in multiple sclerosis: effects of neurotrophic therapy].

  2013cited by this paper
• Brain amyloid and cognition in Lewy body diseases

  2012cited by this paper
• Cerebrospinal fluid α‐synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase

  2012cited by this paper
• &agr;-Synuclein expression is modulated at the translational level by iron

  2012cited by this paper
• 1.050 SLEEP DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE

  2012cited by this paper
• Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis

  2012cited by this paper
• The molecular basis of neurodegeneration in multiple sclerosis

  2011cited by this paper
• Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson’s Disease

  2011cited by this paper
• An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis

  2011cited by this paper
• Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

  2010cited by this paper
• Гипергомоцистеинемия при болезни Паркинсона - новый вариант осложнений проводимой терапии или специфический биохимический маркер заболевания?

  2008cited by this paper
• Современные представления об этиопатогенезе гиперпластических процессов эндометрия у женщин в перименопаузе

  2007cited by this paper
• Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

  2007cited by this paper
• Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice.

  2003cited by this paper
• [Dopamine agonist in the treatment of Parkinson's disease].

  1997cited by this paper

• Methylethylpyridinol in ophthalmology: Mechanisms of action and clinical results

  2025cites this paper
• [Traumatic brain injury as risk factor of Alzheimer's disease and possibilities of pathogenetic therapy].

  2024cites this paper
• Experimental rationale for the use of thioctic acid and indomethacin in the therapy of the early stage of retinal neurodegeneration

  2024cites this paper
• Modern view on the use of alpha lipoic acid in neurological practice

  2024cites this paper
• Noninvasive Therapies: A Forthcoming Approach to Parkinson's Treatment.

  2024cites this paper
• Traumatic Brain Injury as a Risk Factor for Alzheimer’s Disease and Potential for Pathogenetic Therapy

  2024cites this paper
• [Psychological, psychiatric and neurological aspects of COVID-19].

  2023cites this paper
• Brait–Fahn–Schwarz disease (result of two-year clinical follow-up)

  2023cites this paper
• Calciopathies and Neuropsychiatric Disorders: Physiological and Genetic Aspects

  2023cites this paper
• Monotherapy or complex treatment? Tactics of managing patients with Alzheimer’s disease and vascular dementia

  2022cites this paper
• Features of innate and adaptive immunity in patients with Parkinson's disease

  2022cites this paper
• On a New Paradigm of the Development of Neurodegenerative Diseases by the Example of Alzheimer’s Disease and Parkinson’s Disease

  2022cites this paper
• Infectious hypothesis of neurodegenerative diseases. What waits us after the COVID-19 pandemic?

  2022cites this paper
• The role of glutamine synthetase expression and cystine/glutamate transporter (SLC7A11, xCT) in epilepsy pathogenesis of patients with supratentorial brain gliomas

  2022cites this paper
• Multysensory disorders in neurodegenerative diseases related to aging

  2022cites this paper
• The disorder of the iron metabolism as a possible mechanism for the development of neurodegeneration after new coronavirus infection COVID-19

  2021cites this paper
• The disorder of the iron metabolism as a possible mechanism for the development of neurodegeneration after new coronavirus infection of SARS-CoV-2

  2021cites this paper
• Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3β/β-Catenin Signaling Pathway Inhibits Cell Apoptosis in Parkinson's Disease

  2021cites this paper
• The use of a pharmabiotic based on the Lactobacillus fermentum U-21 strain to modulate the neurodegenerative process in an experimental model of Parkinson disease

  2020cites this paper
• Overexpression of miR-153 promotes oxidative stress in MPP+-induced PD model by negatively regulating the Nrf2/HO-1 signaling pathway.

  2018cites this paper
• Evaluation of Gut Microbiota in Parkinson’s Disease using Gas Chromatography with Mass Spectrometric Detection

  2018cites this paper